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SUMMARY
Campylobacter occur in fresh retail poultry products as a result of their colonization of the
gastro-intestinal tract of chickens during growth. Feed additives could be used for suppres-
sion of Campylobacter levels in the chickens prior to slaughter. To address this opportunity,
feed manufacturers are targeting natural antimicrobials from plant material as new forms of
consumer-accepted feed additives. However, to be practical, these natural antimicrobials must
be effective at low concentrations. The current study has validated an improved laboratory
method to study minimal inhibitory concentrations of plant compounds and their combinations
against Campylobacter. The assay was shown to be valid for testing lipid-soluble and water-
soluble plant extracts and byproducts from the food industry. The study screened 29 extracts or
plant-derived compounds and their mixtures for anti-Campylobacter activity using a laboratory
assay. Combinations of oregano, lactic acid, and sorghum byproduct showed effective synergy in
anti-Campylobacter activity. The synergies allowed a large reduction in the concentration of the
individual compounds needed to kill the bacteria with an 80% reduction in concentration being
achieved for oregano essential oil. The assay gives rise to further opportunities for the testing of
a greater range of combinations of plant-derived compounds and other natural antimicrobials.
The method is robust, simple, and easily automated, and it could be used to adjust the cost of
feed formulations by reducing costs associated with antimicrobial feed additives.
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DESCRIPTION OF PROBLEM
Campylobacteriosis has been the most com-
monly reported bacterial-derived food-borne
disease in developed countries during the last
decade [1, 2] with a reported annual cost of
2.4 billion Euros in the European Union [3].
1Corresponding author: y.sultanbawa@uq.edu.au
Chicken meat is the main source of infection in
humans [4]. Consequently, the control ofCampy-
lobacter infections in poultry has become the
main target to reduce the incidence of human
campylobacteriosis [5–7]. The poultry industry
has been trying to reduce Campylobacter colo-
nization by improving biosecurity measures in
production sites to avoid contamination of pro-
duction facilities and cross contamination by in-
fected birds [8, 9]. In addition, research related
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to the development of vaccines [10–12], specific
bacteriophages [13] and bacteriocins [14, 15]
targeting Campylobacter colonization in com-
mercial avian species has advanced significantly.
New feed additives could also be part of the
solution, but consumers have concerns regard-
ing the use of synthetic additives in animal feed
and their potential residues in meat, leading to
pressure for the development and use of natu-
ral additives [16, 17]. Many essential oils and
plant extracts are generally recognized as safe
(www.accessdata.fda.gov) or the equivalent clas-
sification in different countries and can be used
in foods. In addition, plant byproducts of the food
industry, including those resulting from micro-
bial fermentation, can have good antimicrobial
activity and potential as natural alternatives to
synthetic antimicrobials [18]. In recent years nu-
merous studies have shown that Campylobacter
species are sensitive to a wide variety of plant
extracts (e.g., Acacia decurrens, Alpinia kat-
sumada, basil, capsicum, cinnamon bark, clove,
garlic, laurel, lemon, lemon grass, lemon myr-
tle, mandarin, bitter and sweet orange, oregano,
rosemary, sage, and thyme), plant-derived com-
pounds (e.g., anethole, carvacrol, cinnamalde-
hyde, citral, curcumin, eugenol, thymol, and
vanillin) [19–31]. The mechanism by which this
toxicity occurs in bacteria is still unclear. Re-
cently, Nowotarska et al. [32], usingmodelmem-
branes, were able to associate the phenolic group
of carvacrol with the penetration of the com-
pound into the lipid molecules of the bacterial
membrane. With Campylobacter, carvacrol has
been linked to a reduction in motility of the
bacterium, with a consequent reduction of its
infectivity [23]. In other pathogens like Bacil-
lus cereus, Staphyloccocus aureus, and Pseu-
domonas aeruginosa, it has been shown that car-
vacrol and oregano affect the essential metabolic
process in the cell which leads to death [33–34].
Sorghum byproducts available from the
bioethanol industry in Australia are available
on a large-scale [35]. In this industrial process,
sorghum is fermented using the yeast Saccha-
romyces cerevisiae to produce ethanol. Sorghum
syrup is a byproduct of this extraction process
and contains bioactive compounds. Other fer-
mented products from sorghum, like porridge,
are reported to exhibit higher antimicrobial ac-
tivity than the original nonfermented extract
although the content of most phenolic acids de-
creased after fermentation [36–37].
However, as showed in Table 1, it is difficult
to compare the antimicrobial results of plant-
derived compounds and organic acids between
publications [19, 23–27, 38–40], because differ-
ent techniques have been used to determine the
minimum inhibitory concentration (MIC).
Disk diffusion antimicrobial assays have been
widely used, but are laborious and the solu-
bility and diffusion of the substances can be
variable and affect the results [41]. The use
of methods based on microdilutions has been
shown to be more appropriate for the determi-
nation of MIC values [41]. Broth dilution as-
say using 96-well microtiter plates have been
applied to detect the antimicrobial activity of
many substances [42–44]. The microplate as-
says are simple, rapid, reproducible, and inex-
pensive, and can be automated to screen a large
number of samples and bacterial strains [45].
However, studies on the use of microplate assays
to study anti-Campylobacter activity of plant-
derived compounds are limited. The objective
of this study was to adapt and validate a 96 mi-
crowell assay tomeasure the anti-Campylobacter
activity of both lipid-soluble and water-soluble
natural plant-derived substances in one universal
assay format. The ability to compare and com-
bine different types of compounds and extracts
was then used to study combinations of samples
to look for synergies that could lower the overall
concentrations and costs of active compounds
needed to achieve microbial activity in poultry
feed.
MATERIALS AND METHODS
Microplate Assay for Campylobacter
Anti-Campylobacter activities were tested in
a 96-well microplate assay system based on the
work of Bishop-Hurley et al. [46]. The assay
determines the MIC values and correlates the
concentration of the substances tested with the
degree of inhibition of bacterial growth.
In order to screen a variety of plant extracts
and essential oils that vary in their solvent solu-
bilities, specific adaptations to the method were
developed following the procedures of Sultan-
bawa et al. [47]. To explore the interactions and
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Table 1. Antimicrobial effects of essential oil, pure compounds, and
organic acids on Campylobacter spp. reported in the literature.
Essential Oils, Plant-Derived Anti-Campylobacter References
Compounds, and Organic Acids Activity Reported (%)1
MIC 0.05 [27]
Cinnamon bark MIC 0.42 to 1 [23]
BA50 0.021 [19]
MIC 0.05 [27]
Clove bud oil MIC 0.06 to 0.25 [23]
BA50 0.016 [19]
MIC >1 [27]
Garlic
MIC 0.25 to 1 [23]
BA50 0.045 [19]
Lemon
MIC >4 [25]
BA50 0.018 [19]
Lemon grass
MIC 0.42 to 1.33 [23]
MIC 0.002 to 0.125 [26]
MIC 0.0066 [24]
Oregano BA50 0.01 [19]
MIC 0.001 to 0.07 [31]
MIC 0.2 [30]
MIC 0.5 [27]
Rosemary
BA50 0.06 [19]
MIC >1 [27]
Sage
MIC 0.5 [44]
MIC 0.04 [27]
Thyme
BA50 0.022 [19]
MIC 0.12 [38]
Eugenol
BA50 0.022 [19]
MIC 0.2 [30]
Carvacrol MIC 0.12 [38]
MIC 0.006 [28]
BA50 0.0028 [19]
Cinnamaldehyde
MIC 0.2 [30]
BA50 0.024 [19]
Thymol
MIC 0.47 [38]
BA50 >0.67 [40]
Benzoic MIC 0.38 [38]
IC50 0.7 to 2.5 [39]
MIC 19.2 [38]
Citric
IC50 0.23 to 0.57 [39]
MIC >9 [38]
Lactic
IC50 0.9 to 4.6 [39]
MIC 3.35 [38]
Malic
IC50 0.1 to 0.6 [39]
1MIC = Lowest concentration of the compound resulting in 100% inhibition
of bacterial growth. BA50 defined as 50% decrease in the number of cfu. IC50
defined as concentration that decreased bacterial DNA synthesis to 50%.
determine the possible synergies between the
natural substances, a central composite design
[48] was used to generate the checkerboard table
of possible combinations.
Bacteria
Eleven strains of Campylobacter [8 Campy-
lobacter jejuni (1016, 1065, 1110, 1119, 1122,
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1132, 1201, and 1209) and 3Campylobacter coli
(C1951, C1954, C1955)], isolated from chicken
fecal droppings collected from 2 commercial
Australian poultry producers, were used to val-
idate the assay. These strains were stored on
cryo-beads in a −80oC freezer. For every ex-
periment, one bead was aseptically transferred
to a blood agar plate [49] supplemented with 7%
defibrinated sheep blood [50]. The plates were
prepared with defibrinated sheep blood before
each experiment and stored in the refrigerator.
The plates were incubated at 42oC under 5%
CO2 [51–52] and 95% air, atmosphere provided
within a CB150 incubator [53]. This capnophile
condition allows the growth of Campylobacter
and has been extensively utilized in our labo-
ratory. At 24 h, an inoculum of the culture was
recovered with a sterile loop and placed in Nutri-
ent Broth No. 2 [54] enriched with 0.4%Campy-
lobacter growth supplement [55]. The inoculum
was resuspended using the same enriched nu-
trient broth to an optical density of 0.2 A at
595 nm wavelength [56]. The culture was fur-
ther diluted to obtain 104 to 105 cfu/mL, using
the same supplemented nutrient broth. To con-
firm the bacterial count, an aliquot of this di-
luted culture was further diluted and plated onto
sheep blood agar. The inoculum was used in the
96-well plate assay. Each compound/strain was
replicated 9 times.
Essential Oils, Plant-Derived Extracts, and
Organic Acids
The compounds used to develop and vali-
date the assay against Campylobacter strains are
listed in Tables 2 and 3. All the essential oils
and lipid-soluble compounds (carvacrol, citral,
eugenol, cinnamaldehyde, and anethole) were
diluted using a water solution (0.2% wt/vol) of
agar [57]. The sloppy agar solution provides a
stable homogeneous dispersion of the oils. The
agar was prepared, autoclaved, and cooled at
room temperature to form a sloppy agar. Thymol
powder was presolubilized with a 10% (vol/vol)
ethanol solution before dilution in the agar so-
lution. The water-soluble compounds (organic
acids and sorghum syrup) were diluted in sterile
MilliQ-water [58]. The sorghum syrup was ob-
tained as a byproduct from Dalby Bio-Refinery
Ltd [59]. To extract active compounds from
sorghum syrup by-product, accelerated solvent
extraction was performed using the Dionex ASE
200 [60] system. Aliquots of 1.0 g freeze-dried
sorghum syrup was mixed with diatomaceous
earth and placed in a 10-mL stainless steel ex-
traction cell, fitted with a 27-mm cell filter in
the bottom end. The use of a dispersion agent,
such as diatomaceous earth, is recommended to
reduce the solvent volume used for the extrac-
tion. Five different extraction solventswere used:
acetone, ethanol, hexane, methanol (each at a
concentration of 100% wt/wt, analytical grade),
and distilled water. The cells containing sam-
ples were prefilled with the extraction solvents,
pressurized, heated (preheating period= 5 min),
and subjected to 6 extraction cycles, at 60◦C (for
acetone, ethanol, hexane, and methanol) or 80◦C
(for water) and 1,000 psi. The cells were rinsed
with fresh extraction solvent (60% extraction
cell volume) and purged with a flow of nitrogen
(150 psi during 90 s). The extract was collected
into 60-mL amber glass vials. The collected
extracts were concentrated in a miVac sample
concentrator [61] at 45◦C. The concentrated ex-
tracts were weighed and stored at −20◦C until
use.
Accelerated solvent extraction extracts listed
in Table 3 were resuspended in 10% (vol/vol)
ethanol and the sorghum concentrate was sol-
ubilized with 10% Dimethylsulfoxide solution.
All the dilutions were homogenized for 3 min at
3,000 rpm using a vortex mixer [62]. Two-fold
serial dilutions of the treatments were prepared
to determine theMIC inhibition curves (Tables 4
and 5). The compounds with the lowestMIC val-
ues were then selected and retested in isolation
as well as combined at different concentrations
to assess potential synergies (Table 6).
Determination of the MIC and Fractional
Inhibitory Concentrations
The screening assay was carried out using flat
bottom 96-well sterile microtiter plates with lids
[63] to prevent cross contamination. The upper
and bottom rows of wells in each plate contained
the sterilized medium (negative control) and the
Campylobacter strains without inhibitory sub-
stances (positive control), respectively. Interme-
diate rows contained the different concentrations
of the plant compounds and their combinations
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Table 2. Essential oils, pure compounds, and organic acids used in this study.
Essential Oils of Plants Essential Oil Main Component
Anise myrtle (Syzygium anisatum)1 Anethole
Blue gum (Eucalyptus globulus)3 1,8 Cineole
Blue mallee (Eucalyptus polybractea) 3 1,8 Cineole
Cinnamon bark (Cinnamommum zeylanicum)2 Cinnamaldehyde
Clove bud oil (Eugenia caryophyllate)2 Eugenol
Garlic (Allium sativum)2 Allicin
Grapefruit (Citrus paradisi)2 Limonene
Lemon (Citrus limonum)2 Limonene
Lemon grass (Cymbopogon citratus)2 Citral
Lemon myrtle (Backhousia citriodora)1 Citral
Mandarin (Citrus reticulata)2 Limonene
Narrow-leaved peppermint (Eucalyptus radiata)3 1,8 Cineole
Niaouli (Melaleuca quinquenervia ct)3 1,8 Cineole
Oregano (Origanum vulgare)2 Carvacrol
Bitter orange (Citrus aurantium spp amara)2 Limonene
Navel orange (Citrus sinensis)2 Limonene
Rosemary (Rosmarinus officinalis)2 Camphor/1,8 cineole
Sage (Salvia lavandulifolia)2 Camphor/α thujone
Tasmanian native pepper (Tasmannia lanceolata)4 Eugenol
Thyme (Thymus vulgaris)2 Thymol
Pure compounds5
Anethole
Eugenol
Carvacrol
Cinnamaldehyde
Citral
Thymol
Organic acids5
Benzoic
Citric
Formic
Lactic
Malic
Tartaric
1Essential oils supplied by Byron Bay Essential Oils Inc., Tyagarah, NSW 2481,
Australia.
2Australian Botanical Company, Hallam VIC 3803 Australia.
3Essentially Australia, Byron Bay, NSW 2481 Australia.
4Essential Oils of Tasmania Pty Ltd, Kingston, TAS 7051, Australia.
5Sigma–Aldrich, Castle Hill, NSW 1765, Australia.
Table 3. Description of the byproducts of sorghum bio-ethanol production
used in this study.
Sorghum Byproducts Total Polyphenols (Gallic Acid Equivalents, mg/L)
Sorghum syrup1 1,756
Sorghum syrup concentrated Not measured
Solvent extraction of sorghum syrup2
Water2 1,010
Methanol2 579
Ethanol2 307
Acetone2 55
Hexane2 3
1Sorghum syrup samples were a gift from Dalby Bio-refinery Ltd, Dalby, QLD,
Australia.
2Accelerate solvent extraction method.
NAVARRO ET AL.: ANTI-CAMPYLOBACTER ACTIVITY 357
Table 4. Minimum inhibitory concentration of essential oils, pure compounds, and organic acids against
Campylobacter spp1.
Essential Oils MIC Inhibition Essential Oils MIC Inhibition
(%, vol/vol) (%) (%, vol/vol) (%)
Anise myrtle 0.125 132 ± 16 Tasmanian native pepper leaf 0.012 103 ± 6
Blue gum 0.2 102 ± 4 Thyme 0.006 102 ± 4
Blue mallee 0.2 101 ± 2
Cinnamon bark 0.050 101 ± 11 Pure Compounds
Clove bud oil 0.020 108 ± 3 Anethole 0.030 103 ± 14
Garlic 0.050 103 ± 9 Eugenol 0.020 101 ± 6
Grapefruit 0.25 115 ± 15 Carvacrol 0.004 101 ± 8
Lemon 0.25 108 ± 12 Cinnamaldehyde 0.050 100 ± 8
Lemon grass 0.125 107 ± 3 Citral 0.010 103 ± 12
Lemon myrtle 0.012 103 ± 13 Thymol 0.006 102 ± 5
Mandarin 0.25 109 ± 18
Narrow-leaved peppermint 0.1 102 ± 5 Organic Acids2
Niaouli 0.1 107 ± 4 Benzoic 0.060 100 ± 0.3
Oregano 0.0037 103 ± 2 Citric 0.050 102 ± 8
Bitter orange 0.25 116 ± 17 Formic 0.025 101 ± 1
Navel orange 0.25 119 ± 15 Lactic 0.050 103 ± 3
Rosemary 0.015 103 ± 8 Malic 0.050 101 ± 1
Sage 0.150 106 ± 9 Tartaric 0.050 101 ± 0.4
1The MIC values were obtained against 8 strains of Campylobacter jejuni (1016, 1065, 1110, 1119, 1122, 1132, 1201, and
1209) and 3 strains of Campylobacter coli (C1951, C1954, and C1955) using the broth microdilution assay (n = 9 for every
strain and every treatment).
2The pH of the dilution of organic acids ranged from 4.83 to 5.72.
Table 5. Minimum inhibitory concentration of sorghum syrup and
sorghum syrup concentrate against Campylobacter spp.
Sorghum Byproducts1 MIC (%, vol/vol) Inhibition (%)3
Sorghum syrup 1 105 ± 3
Sorghum syrup concentrated 0.25 100 ± 4
Solvent extraction of sorghum syrup2
Water 4 100 ± 0.5
Methanol 4 100 ± 2
Acetone >4 ND
Hexane >4 ND
Ethanol >4 ND
1Campylobacter jejuni (1016, 1065, 1110, 1119, 1122, 1132, 1201, and 1209) and
Campylobacter coli (C1951, C1954, and C1955) using the broth microdilution
assay (n = 9).
2Campylobacter jejuni 1016 and 1065 and Campylobacter coli 1955 using the
broth microdilution assay (n = 9).
3ND = Not determined.
under study. Every treatment was replicated 3
times within a plate and every plate, in turn, was
also replicated 3 times.
Each test well contained 50 μL treatment so-
lution, 100 μL nutrient broth, and 50 μL inocu-
lum. Each negative or sterile control well con-
tained 200μLnutrient broth alone. Each positive
control well contained 50μL bacterial inoculum
and 150 μL nutrient broth. The treatment was
placed first in the wells followed by the nutrient
broth. The bacteria were added at the end of the
procedure.
The plates were shaken for 1 min with a mi-
croplate shaker Titertek [64] immediately be-
fore determining the initial optical density of the
wells measured at 595 nm wavelength (OD595)
by light spectrophotometry [65]. The OD595 was
measured again using the same protocol at 24
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and 48 h of incubation in capnophile conditions
(5% CO2, 42oC).
The growth inhibitory capacities of the com-
pounds tested were calculated using the follow-
ing formula: percentage of inhibition= [1−(T48
OD595 − T0 OD595)/(C48 OD595 − C0 OD595)]
× 100, where T0 and T48 refer to the treatment
wells at the start and 48 h respectively, whereas
C0 and C48 refers to positive control wells at
the start and 48 h, respectively. The MIC was
defined for each compound as the lowest con-
centration of the compound resulting in 100%
inhibition of bacterial growth. To confirm com-
plete inhibition, an inoculum of the tested well
(100 μL) was plated in sheep blood agar and in-
cubated for 48 h in microaerophilic conditions
described above. No growth during 48 h con-
firmed complete inhibition.
Interactions between the natural antimicro-
bials were evaluated by the checkerboardmethod
[66]. The fractional inhibitory concentration
(FIC) index of each combination was calculated
based on the MIC values of the compound in
combination relative to the MIC value of the
compound alone (FIC of compound “a” is re-
ferred to as FICa = MICa combination/MICa
alone). The FIC index of the combination is ob-
tained following the formula: FICab = FICa
+ FICb [67]. Based on the FIC values the
combined effects of the plant compounds were
categorized as either synergy or, addition or in-
difference or antagonism according to the fol-
lowing scale: FIC ≤ 0.5, synergy; FIC = 0.51 to
1, additive; FIC= 1.01 to 2, indifference; FIC>
2, antagonism.
The results were analyzed for statistical dif-
ferences using ANOVA and Fisher’s LSD pro-
cedure of XLSTAT [68] at a 5% significance
level. The CV was calculated and it was less
than 10% for all the calculations where 9 repli-
cates were done for each treatment against the
selected Campylobacter strains.
RESULTS AND DISCUSSION
The main focus of the study was the study
of natural antimicrobials against Campylobac-
ter spp. to determine potential usefulness as ac-
tive compounds to reduce gut colonization in
the chicken. Sixteen essential oils, 7 pure es-
sential oil compounds, 6 organic acids, and 7
sorghum industry byproducts were tested against
11 Campylobacter strains using flat bottom 96-
well sterile microtiter plates. Levels of phe-
nolic compounds were also obtained in the
sorghum syrup and its extractions (Table 3). All
tested compounds showed a dose-dependent re-
sponse against Campylobacter indicating higher
the dose tested the higher the inhibition. How-
ever, the MIC was independent of the strain
of Campylobacter jejuni or Campylobacter coli
used (P > 0.005). The MIC values of each
product tested are given in Tables 4 and 5.
Oregano and thyme essential oils resulted in
the highest anti-Campylobacter activity (MIC of
0.0038 and 0.006%, respectively) only matched
by their main active components carvacrol for
oregano and thymol for thyme. Very low anti-
Campylobacter MIC values below 0.02% were
also identified for citral, eugenol, lemon myrtle,
rosemary, and Tasmanian native pepper leaf. A
group of compounds from clove, anethole, cin-
namon bark, garlic, and lemon myrtle as well as
cinnamaldehyde showed middle range MIC val-
ues between 0.020 and 0.05%. The essential oils
of anise myrtle, blue gum, blue mallee, lemon
grass, lemon, mandarin, narrow-leaved pepper-
mint, niaouli, sage, grapefruit, bitter orange, and
navel orange all had MIC values between 0.125
and 0.25%. The most active organic acid against
Campylobacterwas formic acid, with an MIC of
0.025%. The MIC value for citric, lactic, malic,
and tartaric acids was 0.05%, while that for ben-
zoic acid was 0.06%. The pH range for these
organic acids was in the range 4.83 to 5.72. At
acidic pH most of the organic acid would be
in the undissociated form, which is lipophilic
and enables the diffusion of the acid through the
bacterial cell membrane [69]. This clearly indi-
cates that growth inhibition of Campylobacter
in this study is due to the low pH and not the
organic acid. Seven sorghum byproducts from
bioethanol production were also active against
Campylobacter with MIC values ranging from
0.25% for the rotatory concentrated sorghum
syrup up to 4% for the methanol and water ex-
tractions.
As oregano essential oil showed the strongest
anti-Campylobacter activity (MIC 0.0038%), it
was retested at a wide range of concentrations.
Oregano showed some activity from 0.0005%
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level with increased inhibition of Campylobac-
ter growth up to 0.0038% that showed 100% in-
hibition in all the Campylobacter strains tested
in this assay.
The effectiveness of synergistic interaction
of plant-derived antimicrobials has been known
for a long time [17, 70], and is based on the
principle that the combinations of active com-
pounds enhances the efficacy, while reducing
the toxicity and quantity of substance in the final
formula. However, existing literature addressing
interactions between plant-derived antimicrobial
compounds is scattered and difficult to interpret
[71]. In addition, there is very little compre-
hensive information available regarding plant-
derived compound synergies against Campy-
lobacter. The final goal of this study was to
determine combinations of compounds showing
the strongest synergies at the lowest concentra-
tions possible. Oregano had the lowest MIC val-
ues against theCampylobacter strains tested and
was selected as the base compound to test binary
and ternary combinations. The results presented
in Table 6 are expressed using the FIC index
previously described in the Materials and Meth-
ods section. The binary combination of oregano
with thyme and oregano with cinnamon bark re-
sulted in a synergistic increase of MIC efficacy
for both compounds (Table 6). Combinations
of oregano with lemon myrtle, Tasmanian na-
tive pepper leaf, clove bud, orange, or grapefruit
only showed additive effects. Synergy effects
were also uncovered for binary combinations of
oregano with formic acid, while additives effects
were revealed for binary combination with lac-
tic acid. There was a slight synergistic interac-
tion between oregano and the sorghum syrup
byproduct with an FIC index of 0.55, which was
slightly over the synergy threshold value of 0.5.
Although formic acid showed the best results,
lactic acid was studied in tertiary combinations,
because of its common occurrence and antimi-
crobial use in foods. Lactic acid shows high ac-
tivity against Campylobacter and the ability to
inhibit the growth of many other Gram–negative
species of the Enterobacteriaceae bacteria [72].
In addition to its antimicrobial effect by lowering
of the pH, lactic acid also acts as a permeabilizer
of the Gram-negative bacterial outer membrane
[73]. Lactic acid is related to the development of
nonpathogenic competitive species such as Lac-
tobacillus [14], which are one of the predom-
inant bacterial populations in the chicken ceca
[74]. When lactic acid was added to the formula
in a ternary combination, i.e., oregano, sorghum
syrup, and lactic acid, it showed significant syn-
ergy in antimicrobial activity at the concentra-
tion of 0.0005, 0.015, and 0.01%, respectively.
Oregano (Origanum vulgare) essential oil is
one of the most studied essential oils exhibit-
ing antibacterial activity against a broad range
of bacteria, both Gram-negative and Gram-
positive[19], and recently has been shown to
have antivirus properties as well [75]. Although
the antimicrobial mechanism is still unclear, it
has been speculated that the lipophilic charac-
ter of the main oregano constituents (carvacrol,
thymol, and p-cymene) interacts with the lipid
membranes of the bacteria [76], and may pro-
duce a bacterial destabilization [33, 77].
To the best of our knowledge, this is the first
time that a significant antimicrobial activity has
been reported in sorghum syrup a byproduct
from large-scale bio-ethanol production.
Svensson et al. [36] reported on the conver-
sion of phenolic acid present in the sorghum
grain to flavonoid aglycones during fermen-
tation, of sorghum porridges, which could
compensate for the decrease in phenolic acid
content and increase in the antimicrobial
activity.
Recently, Borges et al. [37] have verified that
phenolic acids from sorghum, changed bacterial
hydrophobicity, affecting the physicochemical
surface properties of bacterial cells [37]. These
authors hypothesize that the antibacterial activ-
ity of phenolic acids is associated with both the
affinity for the lipid bilayer and the disruption
of the membrane. We suggest that the combina-
tion of lipophilic antimicrobial compounds from
oregano essential oil and hydrophilic compounds
from sorghum syrup can affect the integrity of
Campylobacter membrane in a complementary
way. Lactic acid in the plant-derived combina-
tion may complement the antimicrobial effect
in the destabilization of the outer membrane of
Campylobacter and potentiate the lethality by
acidifying the cell cytoplasm.
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CONCLUSIONS AND
APPLICATIONS
The 96-well microplate assay in this study
was used to test combinations of oregano with
organic acid and other plant-derived byproducts
like sorghum syrup from bio-ethanol production.
New plant-derived antimicrobials and their com-
binations against Campylobacter could also be
screened using this assay. This could lead to the
development of potent cost-effective combina-
tions that can be used to reduce Campylobacter
colonization in chickens.
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